Vertex Pharmaceuticals Inc VRTX
(Start of Section) | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Inkomsten | 100,00% | 100,00% | 100,00% | 100,00% | 100,00% |
|---|
| Kosten van inkomsten | 13,16% | 11,86% | 11,94% | 12,10% | 12,79% |
|---|
| Brutomarge | 86,84% | 88,14% | 88,06% | 87,90% | 87,21% |
|---|
| SG&A | 15,82% | 12,42% | 11,09% | 10,58% | 11,52% |
|---|
| Research and development | 42,15% | 29,48% | 40,28% | 28,44% | 32,05% |
|---|
| Exploitatiemarge | 28,88% | 46,24% | 36,69% | 48,88% | 43,65% |
|---|
| Net Int, Inc and Other | 62,38% | 96,46% | 72,74% | 96,27% | 88,02% |
|---|
| EBT-marge | 33,51% | 50,22% | 36,05% | 47,39% | 44,38% |
|---|
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Belastingtarief | 5,24% | 6,53% | 5,13% | 10,19% | 7,70% |
|---|
| Nettomarge | 28,27% | 43,70% | 30,92% | 37,20% | 36,68% |
|---|
| Rendement op activa | 16,16 | 27,02 | 18,60 | 21,04 | 17,71 |
|---|
| Financiële leverage | 1,37 | 1,35 | 1,33 | 1,30 | 1,29 |
|---|
| Rendement op eigen vermogen | 22,37 | 36,71 | 24,93 | 27,67 | 22,99 |
|---|
